Molecular Remedy of Mitochondrial Defects
Molecular Remedy of Mitochondrial Defects
批准号:
8212077
负责人:
TAKAO YAGI
金额:
$47.26万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-02-01 至 2016-01-31
关键词:
AffectAnimal ModelAnimalsAreaAxonBiochemicalBlindnessBrainCessation of lifeComplexCytochrome c ReductaseDataDefectDemyelinationsDiseaseDisease ProgressionEnzymesExhibitsFemaleFlavin MononucleotideFunctional disorderGanglion Cell LayerGene ExpressionGene MutationGenesGoalsGrantHumanHuman bodyInfusion proceduresInvestigationIronKnowledgeLeber&aposs Hereditary Optic NeuropathyMitochondriaMitochondrial DiseasesModelingModificationMolecularMouse StrainsMultienzyme ComplexesMusMutateMutationNADH oxidaseOxidative PhosphorylationPenetrancePhasePreventionRanvier&aposs NodesRattusRecoveryReportingResearchResearch Project GrantsRetinaRetinal Ganglion CellsRotenoneStagingStructureSulfurSymptomsSystemTechniquesTestingTimeTissuesTransgenic MiceVisionVisual impairmentYeastsbasecofactorhuman diseasemalemitochondrial DNA mutationoxidative damagepublic health relevanceremyelinationrepairedresearch studyrestorationsuperior colliculus Corpora quadrigeminatherapy development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The overall goal of this grant is to seek molecular therapies for diseases resulting from defects of the mitochondrial oxidative phosphorylation system. Complex I is the first of five enzyme complexes that comprise the oxidative phosphorylation system. It has the most intricate structure with 45 different subunits (of these, 7 subunits are mitochondrially encoded (designated ND1-6 and 4L)), one FMN and eight iron- sulfur clusters as cofactors. Complex I defects are involved in many human mitochondrial diseases. Leber's hereditary optic neuropathy (LHON) is recognized as the frequently occurring complex I disease. A new animal model has been developed that involves infusion of rotenone-biobeads into the superior colliculus of the rat brain. Symptoms typical of LHON were observed in the animals, most notably, severely impaired vision. At the same time, there was clearly disorganization of the node of Ranvier as well as demyelination of the RGC axons. However, loss of vision was not accompanied by the hallmarks of LHON such as thinner retinal ganglion cell (RGC) layer and death of RGC which only occurred at a later stage. Furthermore, delivery of the yeast alternative NADH dehydrogenase gene (NDI1) into the rat brain restored the vision to normal level with concomitant reorganization of the node of Ranvier and remyelination of the RGC axons. These findings form the basis of this research project. During this grant term, focus will be made on LHON research with the following specific aims. (i) To investigate mechanism of LHON by using the rat models by administration of mutated human or rat ND4 gene to the retina or rotenone biobeads infusion in the superior colliculus. (ii) To clarify whether the NDI1 gene expression can repair vision loss of the two LHON models and to determine repair window. (iii) To construct transgenic mouse strains carrying the mutated human or mouse ND4 gene for further investigation of LHON such as triggering factors.
PUBLIC HEALTH RELEVANCE: Mitochondria are referred to as the powerhouse of human body. Dysfunction of the enzymes in mitochondria causes many human diseases. This project is concerned with clarifying the mechanism of mitochondrial diseases and developing therapies by using the knowledge from the research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Remedy of Mitochondrial Defects
-
批准号:8792528
-
项目类别:
-
资助金额:$46.15万
-
财政年份:2011
-
负责人:TAKAO YAGI
-
依托单位:
Molecular Remedy of Mitochondrial Defects
-
批准号:8607954
-
项目类别:
-
资助金额:$46.15万
-
财政年份:2011
-
负责人:TAKAO YAGI
-
依托单位:
Molecular Remedy of Mitochondrial Defects
-
批准号:8051502
-
项目类别:
-
资助金额:$49.17万
-
财政年份:2011
-
负责人:TAKAO YAGI
-
依托单位:
Molecular Remedy of Mitochondrial Defects
-
批准号:8403028
-
项目类别:
-
资助金额:$44.74万
-
财政年份:2011
-
负责人:TAKAO YAGI
-
依托单位:
Development of therapies to retard Parkinson's disease
-
批准号:7004553
-
项目类别:
-
资助金额:$29.67万
-
财政年份:2005
-
负责人:TAKAO YAGI
-
依托单位:
Development of therapies to retard Parkinson's disease
-
批准号:7340442
-
项目类别:
-
资助金额:$29.09万
-
财政年份:2005
-
负责人:TAKAO YAGI
-
依托单位:
Development of therapies to retard Parkinson's disease
-
批准号:6869749
-
项目类别:
-
资助金额:$30.38万
-
财政年份:2005
-
负责人:TAKAO YAGI
-
依托单位:
Development of therapies to retard Parkinson's disease
-
批准号:7166047
-
项目类别:
-
资助金额:$28.81万
-
财政年份:2005
-
负责人:TAKAO YAGI
-
依托单位:
Development of therapies to retard Parkinson's disease
-
批准号:6479808
-
项目类别:
-
资助金额:$23.15万
-
财政年份:2002
-
负责人:TAKAO YAGI
-
依托单位:
Development of therapies to retard Parkinson's disease
-
批准号:6625890
-
项目类别:
-
资助金额:$23.15万
-
财政年份:2002
-
负责人:TAKAO YAGI
-
依托单位:
PROTEIN STRUCTURE/FUNCTION AND THE RESPIRATORY CHAIN
-
批准号:6307344
-
项目类别:
-
资助金额:$2.74万
-
财政年份:1999
-
负责人:TAKAO YAGI
-
依托单位:
PROTEIN STRUCTURE/FUNCTION AND THE RESPIRATORY CHAIN
-
批准号:6118095
-
项目类别:
-
资助金额:$2.74万
-
财政年份:1998
-
负责人:TAKAO YAGI
-
依托单位:
MOLECULAR REMEDY OF MITOCHONDRIAL DEFECTS
-
批准号:6517430
-
项目类别:
-
资助金额:$25.56万
-
财政年份:1997
-
负责人:TAKAO YAGI
-
依托单位:
MOLECULAR REMEDY OF MITOCHONDRIAL DEFECTS
-
批准号:6752052
-
项目类别:
-
资助金额:$25.56万
-
财政年份:1997
-
负责人:TAKAO YAGI
-
依托单位:
MOLECULAR REMEDY OF MITOCHONDRIAL DEFECTS
-
批准号:2446324
-
项目类别:
-
资助金额:$13.17万
-
财政年份:1997
-
负责人:TAKAO YAGI
-
依托单位:
Molecular Remedy of Mitochondrial Defects
-
批准号:7053387
-
项目类别:
-
资助金额:$34.13万
-
财政年份:1997
-
负责人:TAKAO YAGI
-
依托单位:
Molecular Remedy of Mitochondrial Defects
-
批准号:7233955
-
项目类别:
-
资助金额:$33.14万
-
财政年份:1997
-
负责人:TAKAO YAGI
-
依托单位:
PROTEIN STRUCTURE/FUNCTION AND THE RESPIRATORY CHAIN
-
批准号:6279290
-
项目类别:
-
资助金额:$2.73万
-
财政年份:1997
-
负责人:TAKAO YAGI
-
依托单位:
MOLECULAR REMEDY OF MITOCHONDRIAL DEFECTS
-
批准号:6635086
-
项目类别:
-
资助金额:$25.56万
-
财政年份:1997
-
负责人:TAKAO YAGI
-
依托单位:
Molecular Remedy of Mitochondrial Defects
-
批准号:7418949
-
项目类别:
-
资助金额:$33.1万
-
财政年份:1997
-
负责人:TAKAO YAGI
-
依托单位:
海外基金